US health officials in talks with 14 companies over drug prices, Kennedy says
WASHINGTON, Aug 26 (Reuters) - The United States is in negotiations with 14 companies over its plan to implement so-called most-favored-nation pricing on pharmaceutical drugs, Health Secretary Robert F. Kennedy Jr. said on Tuesday.
Kennedy made the comments in a Cabinet meeting alongside U.S. President Donald Trump.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
Intel Q1 Earnings Preview: Triple Test of CPU, 18A Yields and Foundry Orders

Allbirds Ditches Sneakers and Pivots to AI Computing - Is BIRD Stock Still Worth Buying After a 600% Surge?

Bitcoin Breaks $78,000 Amid U.S.-Iran Conflict, Can It Return to $100,000 in 2026?

Asia-Pacific Stocks Rise Across the Board Monday as Easing Middle East Tensions Boost Market Sentiment

Nvidia Launches Ising Model Driving Quantum Sector Surge, QUBT vs IONQ, Which Is More Worth Investing In?

Tradingkey








